3-hydroxyflavone has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SG; Choi, HY; Kang, GH; Kim, JH; Kim, Y; Koo, BN; Lee, C; Lee, ER; Song, M | 1 |
1 other study(ies) available for 3-hydroxyflavone and imatinib mesylate
| Article | Year |
|---|---|
Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Death; Cell Survival; Cells, Cultured; Dogs; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Humans; Imatinib Mesylate; K562 Cells; Leukemia; Piperazines; Pyrimidines | 2012 |